RNAi technologies: a screen whose time has arrived.

RNAi technologies: a screen whose time has arrived. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

RNAi technologies: a screen whose time has arrived. Abstract Text:

Nathan Blow,

RNAi technologies: a screen whose time has arrived. Publishing Authors By Initials

N Blow,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

RNAi technologies: a screen whose time has arrived. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Nature methods

VOLUME: 5

Page Numbers: 361-8

Journal Abbreviation:

ISSN: 1548-7105

DAY: 31

MONTH: Apr

YEAR: 2008

RNAi technologies: a screen whose time has arrived. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101215604

RNAi technologies: a screen whose time has arrived. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: RNAi technologies: a screen whose time has arrived. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for RNAi technologies: a screen whose time has arrived.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Nat Methods

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

RNAi technologies: a screen whose time has arrived Related Publications

• Access to and satisfaction with care comparing patients with and without serious mental illness.
• Boy or girl--parental choice?
• Brief alcohol intervention in the emergency department: moderators of effectiveness.
• DNA sequencing: generation next-next.
• Dormant origins licensed by excess Mcm2 7 are required for human cells to survive replicative stress.
• ELYS/MEL-28 chromatin association coordinates nuclear pore complex assembly and replication licensing.
• Gender differences in health-related quality of life for veterans with serious mental illness.
• Genomics: when the chemistry is good.
• Improving Integrated General Medical and Mental Health Services in Community-based Practices.
• Lab automation: tales along the road to automation.
• Metabolomics: Biochemistry's new look.
• Metagenomics: exploring unseen communities.
• Nanotechnology in biology: big collaborations for a small world.
• Nanotechnology: Could it be a small world after all?
• Nutrition and exercise behavior among patients with bipolar disorder.
• Oral health in Veterans Affairs patients diagnosed with serious mental illness.
• POLYVALENT INFLUENZA VACCINE IN GENERAL PRACTICE.
• PTIP/Swift is required for efficient PCNA ubiquitination in response to DNA damage.
• Psychiatric diagnosis and intervention in older and younger patients in a primary care clinic: effect of a screening and diagnostic instrument.
• Quality of Care for Cardiovascular Disease-related Conditions in Patients with and without Mental Disorders.
• RNAi technologies: a screen whose time has arrived.
• Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts.
• Reinstitutionalization following psychiatric discharge among VA patients with serious mental illness: a national longitudinal study.
• Small RNAs: Delivering the future.
• Social support among veterans with serious mental illness.
• Stem cells: in search of common ground.
• Structural genomics: inside a protein structure initiative center.
• Temporal Profiling of the Chromatin Proteome Reveals System-wide Responses to Replication Inhibition.
• Understanding associations between serious mental illness and HIV among patients in the VA Health System.
• Unhealthy drinking patterns in older adults: prevalence and associated characteristics.